Your browser doesn't support javascript.
loading
Thyroid eye disease following administration of the BNT162B2 COVID-19 vaccine.
Fujita, H; Makino, S; Hasegawa, T; Saima, Y; Tanaka, Y; Nagashima, S; Kakehashi, A; Kaburaki, T.
Affiliation
  • Fujita H; From the Department of Ophthalmology, Saitama Medical Center Jichi Medical University, Saitama-shi, Saitama-ken, Japan.
  • Makino S; Inoda Eye Clinic, Nasushiobara-shi, Tochigi-ken, Japan.
  • Hasegawa T; Department of Ophthalmology, Jichi Medical University, Shimotsuke-shi, Tochigi-ken, Japan.
  • Saima Y; From the Department of Ophthalmology, Saitama Medical Center Jichi Medical University, Saitama-shi, Saitama-ken, Japan.
  • Tanaka Y; Division of Ophthalmology, Nihon University Itabashi Hospital, Itabashi-ku, Tokyo, Japan.
  • Nagashima S; From the Department of Ophthalmology, Saitama Medical Center Jichi Medical University, Saitama-shi, Saitama-ken, Japan.
  • Kakehashi A; Department of Endocrinology and Metabolism, Saitama Medical Center Jichi Medical University, Saitama-shi, Saitama-ken, Japan.
  • Kaburaki T; From the Department of Ophthalmology, Saitama Medical Center Jichi Medical University, Saitama-shi, Saitama-ken, Japan.
QJM ; 116(2): 130-132, 2023 Feb 24.
Article in En | MEDLINE | ID: mdl-36448695
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Graves Ophthalmopathy / COVID-19 Limits: Humans Language: En Journal: QJM Journal subject: MEDICINA Year: 2023 Document type: Article Affiliation country: Japón
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Graves Ophthalmopathy / COVID-19 Limits: Humans Language: En Journal: QJM Journal subject: MEDICINA Year: 2023 Document type: Article Affiliation country: Japón